473 Panel: Pharmaceutical Engineering Challenges As Approached By Chemical Engineers Outside of Pharma (Invited Talks)


Description:
This session will feature presentations and a panel discussion about key technologies that are being implemented in pharmaceutical research, development, and manufacturing. Panelists, chemical engineers from academia and industries outside of pharmaceuticals, will discuss how these innovations are being utilized in their respective fields. The goal of this cross-functional discussion is to spark new problem-solving ideas to technical challenges and to build stronger relations with chemical engineers across multiple fields.

Sponsor:
Pharmaceutical Discovery, Development and Manufacturing Forum
Co-Sponsor(s):
Pharmaceuticals (15B)


Chair:
Jonathan McMullen
Associate Principal Scientist, Chemical Engineering Technology Labs
Merck & Co., Inc.
Chemical Engineering Research and Development
P.O. Box 2000
Rahway, NJ
07065
Email: jonathan.mcmullen@merck.com


Papers:
Introductory Remarks
473a
Process Intensification Strategies in Chemical Synthesis: From Batch to Continuous Operation
Kishori T. Deshpande, The Dow Chemical Company; Jianping Zeng, The Dow Chemical Company; Ajit Vikram, University of Illinois at Urbana-Champaign; Vivek Kumar, University of Illinois at Urbana-Champaign; Utkarsh Ramesh, University of Illinois at Urbana-Champaign; Karthik Balakrishnan, University of Illinois at Urbana-Champaign; Nuri Oh, University of Pennsylvania; Trevor D. Ewers, The Dow Chemical Company; Peter Trefonas III, Dow Electronic Materials Company; Moonsub Shim, University of Illinois at Urbana-Champaign; Paul J. A. Kenis, University of Illinois at Urbana-Champaign
473b
Scaling Down a Purge Bin: A Multiscale Model-Centric Focus on Process Fundamentals
Justin A. Federici, ExxonMobil
473c
Energy Technology for a Carbon Constrained World Can It be Relevant for the Smaller Scale Chemical Processes
Hugo S. Caram, Lehigh University
473d
Automated Continuous Crystallization and Mechanism Assessment of Zeolites
Andrew Teixeira, Worcester Polytechnic Institute
Panel Discussion
Abstract Submissions Closed
See more of this Group/Topical: Pharmaceutical Discovery, Development and Manufacturing Forum
<< Previous Session | Next Session >>